185
Participants
Start Date
April 30, 2020
Primary Completion Date
December 26, 2020
Study Completion Date
December 26, 2020
RhACE2 APN01
Patients will be treated with APN01 intravenously twice daily (BID).
Physiological saline solution
Patients will be treated with placebo intravenously twice daily (BID).
Hvidovre Hospital, Hvidovre
Herlev Gentofte Hospital, Herlev
Nordsjællands Hospital, Hillerød
"State Healthcare Institution State Clinical Hspital № 15 named after O.M. Filatov", Moscow
"Moscow State Budgetary Healthcare Institution City Clinical Hospital №52 of Health Department of Moscow", Moscow
"Moscow State Budgetary Healthcare Institution N.V. Sklifosovsky Research Institute for Emergency Medicine of Health Department of Moscow", Moscow
"Yaroslavl Regional Clinical Hospital for Military Veterans - International Centre for Gerontological Problems Healthy Ageing", Yaroslavl
"State budgetary institution of Healthcare of Tver region Regional clinical hospital", Tver'
Alexandrovskaya Hospital, Saint Petersburg
Saint Petersburg SBHI City Hospital 38 named after N A Semashko, Pushkin
Saint-Petersburg State Budget Healthcare Institution City Hospital 15, Saint Petersburg
"Regional State Budgetary Healthcare Institution Clinical Hospital №1", Smolensk
"Federal State Budgetary Educational Institution of Higher Education Ryazan State Medical University named after I.P. Pavlov HD RF", Ryazan
"Federal State Budgetary Educational Institution of Higher Education Saratov State Medical University named after V.I. Razumovsky HD RF", Saratov
"Regional State Budgetary Educational Institution Clinical Hospital № 5, Barnaul", Barnaul
Medizinische Universität Innsbruck, Innsbruck
Kaiser Franz Josef Spital, 4. Medizinische Abteilung mit Infektions- und Tropenmedizin, Vienna
Medizinische Universität Wien, Vienna
The National University Hospital, Rigshospitalet, Copenhagen
Universitätsklinikum Hamburg-Eppendorf, Hamburg
Klinikum rechts der Isar, Technische Universität München, München
Cambridge University Hospitals NHS Trust/University of Cambridge, Cambridge
Lead Sponsor
Apeiron Biologics
INDUSTRY